Emgality and Asthma - a phase IV clinical study of FDA data

Summary:

Asthma is reported as a side effect among people who take Emgality (galcanezumab-gnlm), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Dupixent, and have Migraine.

The phase IV clinical study analyzes which people have Asthma when taking Emgality. It is created by eHealthMe based on reports of 24,623 people who have side effects when taking Emgality from the FDA, and is updated regularly.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

What is Asthma?

Asthma is found to be associated with 2,096 drugs and 2,614 conditions by eHealthMe. Check the latest studies of Asthma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

24,623 people reported to have side effects when taking Emgality.
Among them, 85 people (0.35%) have Asthma.

Among these 85 people:

How long have people been on Emgality when they have Asthma? *

What is the gender of people who have Asthma when taking Emgality? *

female: 92.59 %
male: 7.41 %

What is the age of people who have Asthma when taking Emgality? *

What are other drugs people take besides Emgality? *

What are other side effects people have besides Asthma? *

Headache (pain in head): 15 people, 17.65%
Nausea (feeling of having an urge to vomit): 13 people, 15.29%
Fatigue (feeling of tiredness): 13 people, 15.29%
Migraine (headache): 13 people, 15.29%
Sinusitis (inflammation of sinus): 11 people, 12.94%
Drug Ineffective: 11 people, 12.94%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 11.76%
Rashes (redness): 10 people, 11.76%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 10.59%
Pneumonia: 9 people, 10.59%

What are the existing conditions these people have? *

Migraine (headache): 28 people, 32.94%
Immunodeficiency Common Variable: 13 people, 15.29%
Primary Immunodeficiency Syndrome: 7 people, 8.24%
Immune System Disorder: 5 people, 5.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 3.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.53%
Headache (pain in head): 2 people, 2.35%
Osteoporosis (bones weak and more likely to break): 2 people, 2.35%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 1.18%
Cough: 1 person, 1.18%

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and have Asthma?

- Check whether Asthma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emgality:

Emgality (24,702 reports)

Asthma treatments and more:

Asthma (354,191 reports)

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Asthma:

Asthma (2,096 drugs)

Browse all the conditions that are associated with Asthma:

Asthma (2,614 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on galcanezumab-gnlm (the active ingredients of Emgality) and Emgality (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.